Randomized Trial of 30 Versus 20 Gy in the Adjuvant Treatment of Stage I Testicular Seminoma: A Report on Medical Research Council Trial TE18, European Organisation for Research and Treatment of Cancer Trial 30942 (ISRCTN18525328)

Abstract

February 20 issue of the Journal of Clinical Oncology, in which they defined the appropriate radiation dose in the adjuvant treatment of stage I seminoma. It was a well done randomized trial, which tried to answer several important questions in the treatment of seminoma. Nearly 90% of the patients in the study received para-aortic strip only irradiation (PAS), without treatment to the pelvis. With reference to Table